Z-1773-2019 Class III Terminated

Recalled by Cardiocommand Inc. — Tampa, FL

FDA device recall Z-1773-2019 was initiated by Cardiocommand Inc. on May 10, 2019 and is designated Class III. Reason for recall: Possible corrosion of the battery contact(s). The recall status is terminated (terminated Apr 12, 2021). Affected quantity: 5 units.

Recall details

Product Type
Devices
Report Date
Jun 19, 2019
Initiation Date
May 10, 2019
Termination Date
Apr 12, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 units

Product description

CardioCommand, Inc. Transesophageal Cardiac Pacing and Recording System, Model 7A, REF 0101 - Product Usage: Indications for Use: - Temporary left atrial pacing to treat bradycardia, hypotension or AV junctional rhythm - Acceleration of heart rate as an alternative to exercise or drugs during diagnostic cardiac studies such as echocardiography or radionuclide ventriculography. - Antitachycardia pacing for cardioversion of supraventricular tachycardia (SVT), including atrial flutter and re-entrant atrial or atrioventricular paroxysmal tachycardia. - Esophageal electrocardiography for differential diagnosis of complex atrial arrhythmia

Reason for recall

Possible corrosion of the battery contact(s).

Distribution pattern

US Nationwide distribution in the states of CT, VW, OH, IL, DE.

Code information

Serial Numbers: 8059, 8060, 8022, 8063, 8211

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1773-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1773-2019. Report a data issue: hello@regdatalab.com.